| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.6M | — | -8.7% |
| Cost of Revenue | $4.5M | — | -26.7% |
| Gross Profit | $16.0M | — | -1.8% |
| R&D Expense | $4.9M | — | +3.0% |
| SG&A Expense | $24.1M | — | -7.8% |
| Operating Income | -$13.0M | — | +11.0% |
| Pre-tax Income | -$13.5M | — | +5.6% |
| Income Tax | $149K | — | +10.4% |
| Net Income | -$13.7M | — | +5.5% |
| EPS (Basic) | -$0.33 | — | +8.3% |
| EPS (Diluted) | -$0.33 | — | +8.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.6M | -11.7% | -17.4% |
| Accounts Receivable | $10.8M | -10.3% | -22.5% |
| Inventory | $16.3M | +2.9% | -3.0% |
| Current Assets | $92.7M | -8.8% | -25.2% |
| Total Assets | $120.0M | -7.2% | -20.4% |
| Current Liabilities | $18.9M | -5.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.1M | — | +23.6% |
| Capital Expenditures | $9K | — | -97.0% |
| Investing Cash Flow | -$9K | — | -100.1% |
| Financing Cash Flow | $2.0M | — | +205.1% |
| Free Cash Flow | -$10.1M | — | +25.3% |
| -24.2% |
| Long-term Debt | $37.3M | +0.6% | +0.3% |
| Total Liabilities | $74.2M | -1.3% | +1.6% |
| Stockholders' Equity | $45.8M | -15.4% | -41.1% |